𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Efficacy of interferon in immunocompromised HCV patients after liver transplantation or with HIV co-infection

✍ Scribed by T. Reiberger; S. Rasoul-Rockenschaub; A. Rieger; P. Ferenci; A. Gangl; M. Peck-Radosavljevic


Book ID
108713648
Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
180 KB
Volume
38
Category
Article
ISSN
0014-2972

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Analysis of a successful HCV-specific CD
✍ Norbert Hubert Gruener; Maria-Christina Jung; Axel Ulsenheimer; Joern Tilman Ger πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 158 KB πŸ‘ 1 views

Virus-specific CD8+ T cells play a major role in antiviral immune defenses; their significance in the transplant setting, however, is unclear. In the present study, we asked whether hepatitis C virus (HCV)-specific CD8+ T cells were detectable in the presence of an immunosuppressive treatment and wh

Loss of serum HBsAg after interferon-A t
✍ Ben-Ari, Z ;Shmueli, D ;Shapira, Z ;Mor, E ;Tur-Kaspa, R πŸ“‚ Article πŸ“… 1997 πŸ› Wiley (John Wiley & Sons) 🌐 English βš– 81 KB πŸ‘ 1 views

Reinfection with hepatitis B virus after orthotopic liver transplantation is nearly universal in patients who have not received posttransplant immunoprophylaxis. Recurrence almost invariably leads to chronic liver disease. Interferon has been used both prophylactically and therapeutically but has no